Brief: Oncopeptides Drug Included In Guidelines For Myeloma
08/07/2025 09:17
July 8 (Reuters) - Oncopeptides AB ONCO.ST: PEPASTI INCLUDED IN EHA-EMN GUIDELINES FOR MYELOMA RECOGNITION SIGNALS BROADER USE OF PEPASTI IN EUROPE Source text: ID:nMFN6W6Fpl Further company coverage: ONCO.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Oncopeptides AB
See all newsSweden's Oncopeptides Q3 net sales rise on Pepaxti demand
Brief: Oncopeptides Q3 Operating Profit SEK -36.47 Million
Brief: Oncopeptides Completes Directed Share Issue Of SEK 100 Mln
Brief: Oncopeptides Confirms Blood-Brain-Barrier Penetration In Glioblastoma Study
Swedish biotech Oncopeptides' Q2 net sales rise on strong demand in Italy